Marco Insights delivers aggregated and anonymized data to pharmaceutical companies about real therapeutic challenges, most-consulted conditions, and recurring physician questions by country and region. It enables market access, medical affairs, and clinical development strategies grounded in real-world intelligence.
Some answers to questions we often receive
Marco Insights delivers aggregated and anonymized analyses on query frequency by condition, predominant therapeutic questions, most-consulted treatments, and regional and institutional trends.
Marco Insights data is updated continuously and can be delivered as periodic reports or through real-time dashboards depending on the subscription type.
Marco Insights reveals the current state of medical knowledge about the target indication: what questions oncologists have, which treatments they reference, and what adoption barriers to anticipate, directly informing medical affairs strategy and sales force training.
Yes. All data is fully anonymized and aggregated before delivery. No insight can be linked to individual patients or physicians.
Yes. By analyzing query patterns by condition, treatment, and region, Marco Insights identifies areas with high therapeutic uncertainty and low penetration of available solutions, revealing niche opportunities for the industry.
Yes. Marco Insights can show the relative frequency with which physicians query different molecules within an indication, revealing the real-world positioning of each product in clinical practice versus the competition.
Pharmaceutical companies lack access to real clinical behavior data that would help them understand where therapeutic gaps exist and how to position their products in a relevant way.
